Company / SG&A Expense
Guardant Health, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$211.4M
FY2025
5-year range
$155.8M / $211.4M
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#103 of 152
Health Care
What the data says
At $211M, Guardant Health, Inc.'s sg&a expense ranks #50 of 152 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $10M in FY2016 to $211M in FY2025.
Based on SEC 10-K filings.
$211M in FY2025 with a 5-year CAGR of +1.9%.
Increased from $156M to $211M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Sector benchmark
#50 of 152 in Health CareTop 32% of 152This company $211.4M Sector average $182.7B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.9%, indicating consistent growth.
- In FY2025, sg&a expense increased 17.4% year-over-year.
- Ranks #103 out of 152 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $211.4M | +17.4% |
| FY2024 | $180.1M | +15.6% |
| FY2023 | $155.8M | -5.0% |
| FY2022 | $164.0M | -20.7% |
| FY2021 | $206.6M | +7.2% |
| FY2020 | $192.8M | +214.0% |
| FY2019 | $61.4M | +69.6% |
| FY2018 | $36.2M | -1.6% |
| FY2017 | $36.8M | +270.7% |
| FY2016 | $9.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026